Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder and a leading cause of dementia, with accumulation of amyloid-beta (Aβ) and neurofibrillary tangles (NFTs) as defining pathological features. AD presents a serious global health concern with no cure to date, refl...
Main Authors: | Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Iekhsan Othman, Khurram Aamir, Mohd. Farooq Shaikh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/2/383 |
Similar Items
-
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
by: Yam Nath Paudel, et al.
Published: (2018-09-01) -
HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities
by: Yam Nath Paudel, et al.
Published: (2020-06-01) -
Modulatory actions of HMGB1 on TLR4 and rage in the primary afferent sensory neuron
by: Allette, Yohance Mandela
Published: (2015) -
HMGB1 in inflammation and cancer
by: Shumin Wang, et al.
Published: (2020-08-01) -
HMGB1: The Central Cytokine for all Lymphoid Cells
by: Guanqiao eLi, et al.
Published: (2013-03-01)